Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Rises 8.4 Percent

Shares of Third Wave Technologies rose 8.4 percent for the five-day trading period ended Tuesday. The firm’s stock is up 17.7 percent since announcing on Dec. 5 that it had received the CE Mark for its HPV molecular diagnostic test, allowing it to sell the test throughout the European Union.
 
Qiagen led decliners for the week with a drop of 5.9 percent. Overall, 16 of the 21 stocks in the BCW Index lost value during the tracking period, and the Index closed down 1.1 percent.
 
In comparison, the Dow Jones Industrial Average fell 1.5 percent, the Nasdaq declined 2.1 percent, and the Nasdaq Biotech Index dropped 2 percent for the week.

 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(December 18, 2007)
Last
Price
(December 11, 2007)
% change
Affymetrix
AFFX
23.23 21.66 7.25
Agilent
A
35.11 36.47 -3.73
Applied Biosystems
ABI
32.91 34.07 -3.40
Beckman
BEC
69.96 73.47 -4.78
Becton Dickinson
BDX
82.37 82.39 -0.02
Bio-Rad
BIO
100.15 101.30 -1.14
Bruker
BRKR
11.89 12.07 -1.49
Caliper
CALP
5.56 5.67 -1.94
Cepheid
CPHD
24.23 24.30 -0.29
Illumina
ILMN
54.94 56.45 -2.67
Invitrogen
IVGN
93.62 93.65 -0.03
Luminex
LMNX
16.14 15.13 6.68
MDS
MDZ
18.67 19.43 -3.91
Millipore
MIL
74.42 75.68 -1.66
PerkinElmer
PKI
24.63 25.16 -2.11
Qiagen
QGEN
20.70 21.99 -5.87
Sequenom
SQNM
7.91 7.80 1.41
Sigma-Aldrich
SIAL
54.30 53.46 1.57
Thermo
TMO
56.70 57.43 -1.27
Third Wave
TWTI
9.42 8.69 8.40
Waters
WAT
77.29 77.94 -0.83
BCW Index Average 42.58 43.06
-1.11
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.